Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 23, 2023 - Issue 8
Submit an article Journal homepage
103
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Evaluating the correlations of cost and utility parameters from summary statistics for probabilistic analysis in economic evaluations

Xuanqian Xiea Health Technology Assessment Program, Ontario Health, Toronto, ON, CanadaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-4331-8233View further author information
ORCID Icon,
Alexis K. Schainka Health Technology Assessment Program, Ontario Health, Toronto, ON, CanadaView further author information
,
Chengyu Gaob Department of Mathematics and Statistics, University of Regina, Regina, SK, CanadaView further author information
,
Olga Gajic-Veljanoskia Health Technology Assessment Program, Ontario Health, Toronto, ON, CanadaORCID Iconhttps://orcid.org/0000-0002-5024-1641View further author information
ORCID Icon,
Wendy J. Ungarc Program of Child Health Evaluative Sciences, The Hospital for Sick Children Research Institute, Toronto, ON, Canada;d The Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, CanadaORCID Iconhttps://orcid.org/0000-0002-0762-0101View further author information
ORCID Icon &
Andrei Volodinb Department of Mathematics and Statistics, University of Regina, Regina, SK, CanadaORCID Iconhttps://orcid.org/0000-0002-9771-846XView further author information
ORCID Icon
Pages 901-909 | Received 25 Mar 2023, Accepted 30 May 2023, Published online: 12 Jun 2023

References

  • Schober P, Boer C, Schwarte LA. Correlation coefficients: appropriate use and interpretation. Anesth Analg. 2018 May;126(5):1763–1768.
  • Ratzki-Leewing A, Harris SB, Mequanint S, et al. Real-world crude incidence of hypoglycemia in adults with diabetes: results of the InHypo-DM study, Canada. BMJ Open Diabetes Res Care. 2018;6(1):e000503. doi:10.1136/bmjdrc-2017-000503
  • Naversnik K, Rojnik K. Handling input correlations in pharmacoeconomic models. Value Health. 2012 May;15(3):540–549.
  • Canadian Agency for Drugs and Technologies in Health. Guidelines for the economic evaluation of health technologies: Canada. 4th ed. Ottawa (ON): The Agency; 2017. p. 76.
  • Briggs AH, Weinstein MC, Fenwick EA, et al. Model parameter estimation and uncertainty: a report of the ISPOR-SMDM modeling good research practices task force–6. Value Health. 2012;15(6):835–842. doi:10.1016/j.jval.2012.04.014
  • Mukaka MM. Statistics corner: a guide to appropriate use of correlation coefficient in medical research. Malawi Med J. 2012 Sep;24(3):69–71.
  • Ontario Health. Multi-gene pharmacogenomic testing that includes decision-support tools to guide medication selection for major depression: a health technology assessment. Ont Health Technol Assess Ser. 2021;21(13):1–214.
  • Wicklin R. Simulating data with SAS. Cary NC: SAS Institute Inc; 2013.
  • R: a language and environment for statistical computing [Computer program]. Vienna: R Foundation for Statistical Computing; 2022.
  • Briggs A, Sculpher M, Claxton K. Decision modelling for health economic evaluation. Oxford (UK): Oxford University Press; 2006.
  • Gut A. An intermediate course in probability. 2nd ed. New York: Springer-Verlag; 2009. doi:10.1007/978-1-4419-0162-0
  • Tanner JA, Hensel J, Davies PE, et al. Economic burden of depression and associated resource use in Manitoba, Canada. Can J Psychiatry. 2020 May;65(5):338–346.
  • Brod M, Christensen T, Thomsen TL, et al. The impact of non-severe hypoglycemic events on work productivity and diabetes management. Value Health. 2011 Jul;14(5):665–671.
  • Xie X, Guo J, Bremner KE, et al. Review and estimation of disutility for joint health states of severe and nonsevere hypoglycemic events in diabetes. J Comp Eff Res. 2021 Sep;10(13):961–974.
  • Foos V, Varol N, Curtis BH, et al. Economic impact of severe and non-severe hypoglycemia in patients with Type 1 and Type 2 diabetes in the United States. J Med Econ. 2015 Jun;18(6):420–432.
  • Rice JB, Desai U, Cummings AK, et al. Burden of diabetic foot ulcers for medicare and private insurers. Diabetes Care. 2014;37(3):651–658. doi:10.2337/dc13-2176
  • Lugner AK, Krabbe PFM. An overview of the time trade-off method: concept, foundation, and the evaluation of distorting factors in putting a value on health. Expert Rev Pharmacoecon Outcomes Res. 2020 Aug;20(4):331–342.
  • Krahn MD, Bremner KE, Alibhai SM, et al. A reference set of health utilities for long-term survivors of prostate cancer: population-based data from Ontario, Canada. Qual Life Res. 2013 Dec;22(10):2951–2962.
  • Takahara M, Katakami N, Shiraiwa T, et al. Evaluation of health utility values for diabetic complications, treatment regimens, glycemic control and other subjective symptoms in diabetic patients using the EQ-5D-5L. Acta Diabetol. 2019 Mar;56(3):309–319.
  • Devlin NJ, Shah KK, Feng Y, et al. Valuing health-related quality of life: an EQ-5D-5L value set for England. Health Econ. 2018 Jan;27(1):7–22.
  • Pickard AS, Law EH, Jiang R, et al. United States valuation of EQ-5D-5L health states using an international protocol. Value Health. 2019 Aug;22(8):931–941.
  • Peasgood T, Brennan A, Mansell P, et al. The impact of diabetes-related complications on preference-based measures of health-related quality of life in adults with type I diabetes. Med Decis Making. 2016 Nov;36(8):1020–1033.
  • Venables WN, Ripley BD. Modern Applied Statistics with S. 4th ed. New York: Springer; 2002. doi:10.1007/978-0-387-21706-2
  • Hollingworth W, Fawsitt CG, Dixon P, et al. Cost-effectiveness of sertraline in primary care according to initial severity and duration of depressive symptoms: findings from the PANDA RCT. Pharmacoecon Open. 2020 Sep;4(3):427–438.
  • Xie X, Yeung MW, Wang Z, et al. Comparison of the expected rewards between probabilistic and deterministic analyses in a Markov model. Expert Rev Pharmacoecon Outcomes Res. 2020 Apr;20(2):169–175. doi:10.1080/14737167.2019.1615886

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.